Journal of Tuberculosis and Lung Disease ›› 2023, Vol. 4 ›› Issue (2): 98-109.doi: 10.19983/j.issn.2096-8493.20230025
• Special Topic • Previous Articles Next Articles
Received:
2023-02-04
Online:
2023-04-20
Published:
2023-04-07
Contact:
Xie Jianping, Email: CLC Number:
Jiang Zhiyong, Xie Jianping. Structure, substrate and function of mycobacterium type Ⅶ secretory system[J]. Journal of Tuberculosis and Lung Disease , 2023, 4(2): 98-109. doi: 10.19983/j.issn.2096-8493.20230025
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.jtbld.cn/EN/10.19983/j.issn.2096-8493.20230025
[1] |
Pinheiro J, Reis O, Vieira A, et al. Listeria monocytogenes encodes a functional ESX-1 secretion system whose expression is detrimental to in vivo infection. Virulence, 2017, 8(6): 993-1004. doi:10.1080/21505594.2016.1244589.
doi: 10.1080/21505594.2016.1244589 pmid: 27723420 |
[2] |
Spencer BL, Doran KS. Evolving understanding of the type Ⅶ secretion system in Gram-positive bacteria. PLoS Pathog, 2022, 18(7): e1010680. doi:10.1371/journal.ppat.1010680.
doi: 10.1371/journal.ppat.1010680 URL |
[3] |
Aly KA, Anderson M, Ohr RJ, et al. Isolation of a Membrane Protein Complex for Type Ⅶ Secretion in Staphylococcus aureus. J Bacteriol, 2017, 199(23): e00482-17. doi:10.1128/JB.00482-17.
doi: 10.1128/JB.00482-17 |
[4] |
Ohr RJ, Anderson M, Shi M, et al. EssD, a Nuclease Effector of the Staphylococcus aureus ESS Pathway. J Bacteriol, 2016, 199(1): e00528-16. doi:10.1128/JB.00528-16.
doi: 10.1128/JB.00528-16 |
[5] |
Tiwari S, Casey R, Goulding CW, et al. Infect and Inject: How Mycobacterium tuberculosis Exploits Its Major Virulence-Associated Type Ⅶ Secretion System, ESX-1. Microbiol Spectr, 2019, 7(3): 10.1128/microbiolspec.BAI-0024-2019. doi:10.1128/microbiolspec.BAI-0024-2019.
doi: 10.1128/microbiolspec.BAI-0024-2019 |
[6] |
Yimer SA, Kalayou S, Homberset H, et al. Lineage-Specific Proteomic Signatures in the Mycobacterium tuberculosis Complex Reveal Differential Abundance of Proteins Involved in Virulence, DNA Repair, CRISPR-Cas, Bioenergetics and Lipid Metabolism. Front Microbiol, 2020, 11: 550760. doi:10.3389/fmicb.2020.550760.
doi: 10.3389/fmicb.2020.550760 URL |
[7] |
Chirakos AE, Nicholson KR, Huffman A, et al. Conserved ESX-1 Substrates EspE and EspF Are Virulence Factors That Regulate Gene Expression. Infect Immun, 2020, 88(12): e00289-20. doi:10.1128/IAI.00289-20.
doi: 10.1128/IAI.00289-20 |
[8] |
Raffetseder J, Iakobachvili N, Loitto V, et al. Retention of EsxA in the Capsule-Like Layer of Mycobacterium tuberculosis Is Associated with Cytotoxicity and Is Counteracted by Lung Surfactant. Infect Immun, 2019, 87(3): e00803-18. doi:10.1128/IAI.00803-18.
doi: 10.1128/IAI.00803-18 |
[9] |
Lim ZL, Drever K, Dhar N, et al. Mycobacterium tuberculosis EspK Has Active but Distinct Roles in the Secretion of EsxA and EspB. J Bacteriol, 2022, 204(4): e0006022. doi:10.1128/jb.00060-22.
doi: 10.1128/jb.00060-22 URL |
[10] |
Sala C, Odermatt NT, Soler-Arnedo P, et al. EspL is essential for virulence and stabilizes EspE, EspF and EspH levels in Mycobacterium tuberculosis. PLoS Pathog, 2018, 14(12): e1007491. doi:10.1371/journal.ppat.1007491.
doi: 10.1371/journal.ppat.1007491 URL |
[11] |
Pajuelo D, Tak U, Zhang L, et al. Toxin secretion and trafficking by Mycobacterium tuberculosis. Nat Commun, 2021, 12(1): 6592. doi:10.1038/s41467-021-26925-1.
doi: 10.1038/s41467-021-26925-1 pmid: 34782620 |
[12] |
Izquierdo Lafuente B, Ummels R, Kuijl C, et al. Mycobacterium tuberculosis Toxin CpnT Is an ESX-5 Substrate and Requires Three Type Ⅶ Secretion Systems for Intracellular Secretion. mBio, 2021, 12(2): e02983-20. doi:10.1128/mBio.02983-20.
doi: 10.1128/mBio.02983-20 |
[13] |
Abdallah AM, Weerdenburg EM, Guan Q, et al. Integrated transcriptomic and proteomic analysis of pathogenic mycobacteria and their esx-1 mutants reveal secretion-dependent regulation of ESX-1 substrates and WhiB 6 as a transcriptional regulator. PLoS One, 2019, 14(1): e0211003. doi:10.1371/journal.pone.0211003.
doi: 10.1371/journal.pone.0211003 URL |
[14] |
Kudhair BK, Hounslow AM, Rolfe MD, et al. Structure of a Wbl protein and implications for NO sensing by M.tuberculosis. Nat Commun, 2017, 8(1): 2280. doi:10.1038/s41467-017-02418-y.
doi: 10.1038/s41467-017-02418-y pmid: 29273788 |
[15] |
Raze D, Segers J, Mille C, et al. Coordinate regulation of virulence and metabolic genes by the transcription factor HbhR in Mycobacterium marinum. Mol Microbiol, 2020, 113(1): 52-67. doi:10.1111/mmi.14400.
doi: 10.1111/mmi.14400 URL |
[16] |
Elliott SR, White DW, Tischler AD. Mycobacterium tuberculosis Requires Regulation of ESX-5 Secretion for Virulence in Irgm1-Deficient Mice. Infect Immun, 2019, 87(2): e00660-18. doi:10.1128/IAI.00660-18.
doi: 10.1128/IAI.00660-18 |
[17] |
Burggraaf MJ, Speer A, Meijers AS, et al. Type Ⅶ Secretion Substrates of Pathogenic Mycobacteria Are Processed by a Surface Protease. mBio, 2019, 10(5): e01951-19. doi:10.1128/mBio.01951-19.
doi: 10.1128/mBio.01951-19 |
[18] |
Williamson ZA, Chaton CT, Ciocca WA, et al. PE5-PPE4-EspG 3 heterotrimer structure from mycobacterial ESX-3 secretion system gives insight into cognate substrate recognition by ESX systems. J Biol Chem, 2020, 295(36): 12706-12715. doi:10.1074/jbc.RA120.012698.
doi: 10.1074/jbc.RA120.012698 pmid: 32675282 |
[19] |
Tuukkanen AT, Freire D, Chan S, et al. Structural Variability of EspG Chaperones from Mycobacterial ESX-1, ESX-3, and ESX-5 Type Ⅶ Secretion Systems. J Mol Biol, 2019, 431(2): 289-307. doi:10.1016/j.jmb.2018.11.003.
doi: S0022-2836(18)30423-6 pmid: 30419243 |
[20] |
Kriel NL, Newton-Foot M, Bennion OT, et al. Localization of EccA 3 at the growing pole in Mycobacterium smegmatis. BMC Microbiol, 2022, 22(1): 140. doi:10.1186/s12866-022-02554-6.
doi: 10.1186/s12866-022-02554-6 |
[21] |
Famelis N, Rivera-Calzada A, Degliesposti G, et al. Architecture of the mycobacterial type Ⅶ secretion system. Nature, 2019, 576(7786): 321-325. doi:10.1038/s41586-019-1633-1.
doi: 10.1038/s41586-019-1633-1 |
[22] |
Bunduc CM, Fahrenkamp D, Wald J, et al. Structure and dynamics of a mycobacterial type Ⅶ secretion system. Nature, 2021, 593(7859): 445-448. doi:10.1038/s41586-021-03517-z.
doi: 10.1038/s41586-021-03517-z |
[23] |
Damen MPM, Ummels R, et al. Protease domain and transmembrane domain of the type Ⅶ secretion mycosin protease determine system-specific functioning in mycobacteria. J Biol Chem, 2019, 294(13): 4806-4814. doi:10.1074/jbc.RA118.007090.
doi: 10.1074/jbc.RA118.007090 URL |
[24] |
Wang Y, Tang Y, Lin C, et al. Crosstalk between the ancestral type Ⅶ secretion system ESX-4 and other T7SS in Mycobacterium marinum. iScience, 2021, 25(1): 103585. doi:10.1016/j.isci.2021.103585.
doi: 10.1016/j.isci.2021.103585 URL |
[25] |
Wang L, Asare E, Shetty AC, et al. Multiple genetic paths including massive gene amplification allow Mycobacterium tuberculosis to overcome loss of ESX-3 secretion system substrates. Proc Natl Acad Sci U S A, 2022, 119(8): e2112608119. doi:10.1073/pnas.2112608119.
doi: 10.1073/pnas.2112608119 |
[26] |
Osman MM, Shanahan JK, Chu F, et al. The C terminus of the mycobacterium ESX-1 secretion system substrate ESAT-6 is required for phagosomal membrane damage and virulence. Proc Natl Acad Sci U S A, 2022, 119(11): e2122161119. doi:10.1073/pnas.2122161119.
doi: 10.1073/pnas.2122161119 |
[27] |
Rastogi S, Briken V. Interaction of Mycobacteria With Host Cell Inflammasomes. Front Immunol, 2022, 13: 791136. doi:10.3389/fimmu.2022.791136.
doi: 10.3389/fimmu.2022.791136 URL |
[28] |
Beckwith KS, Beckwith MS, Ullmann S, et al. Plasma membrane damage causes NLRP 3 activation and pyroptosis during Mycobacterium tuberculosis infection. Nat Commun, 2020, 11(1): 2270. doi:10.1038/s41467-020-16143-6.
doi: 10.1038/s41467-020-16143-6 pmid: 32385301 |
[29] |
Pattanaik KP, Ganguli G, Naik SK, et al. Mycobacterium tuberculosis EsxL induces TNF-α secretion through activation of TLR2 dependent MAPK and NF-κB pathways. Mol Immunol, 2021, 130: 133-141. doi:10.1016/j.molimm.2020.11.020.
doi: 10.1016/j.molimm.2020.11.020 pmid: 33419561 |
[30] |
Mittal E, Skowyra ML, Uwase G, et al. Mycobacterium tuberculosis Type Ⅶ Secretion System Effectors Differentially Impact the ESCRT Endomembrane Damage Response. mBio, 2018, 9(6): e01765-18. doi:10.1128/mBio.01765-18.
doi: 10.1128/mBio.01765-18 |
[31] |
Portal-Celhay C, Tufariello JM, Srivastava S, et al. Mycobacterium tuberculosis EsxH inhibits ESCRT-dependent CD4+ T-cell activation. Nat Microbiol, 2016, 2: 16232. doi:10.1038/nmicrobiol.2016.232.
doi: 10.1038/nmicrobiol.2016.232 pmid: 27918526 |
[32] |
Wang L, Liu Z, Wang J, et al. Oxidization of TGF β-activated kinase by MPT 53 is required for immunity to Mycobacterium tuberculosis. Nat Microbiol, 2019, 4(8): 1378-1388. doi:10.1038/s41564-019-0436-3.
doi: 10.1038/s41564-019-0436-3 pmid: 31110366 |
[33] |
Ates LS, Dippenaar A, Ummels R, et al. Mutations in ppe38 block PE_PGRS secretion and increase virulence of Mycobacterium tuberculosis. Nat Microbiol, 2018, 3(2): 181-188. doi:10.1038/s41564-017-0090-6.
doi: 10.1038/s41564-017-0090-6 |
[34] |
Madacki J, Orgeur M, Mas Fiol G, et al. ESX-1-Independent Horizontal Gene Transfer by Mycobacterium tuberculosis Complex Strains. mBio, 2021, 12(3): e00965-21. doi:10.1128/mBio.00965-21.
doi: 10.1128/mBio.00965-21 |
[35] |
Jia P, Zhang Y, Xu J, et al. IMB-BZ as an Inhibitor Targeting ESX-1 Secretion System to Control Mycobacterial Infection. J Infect Dis, 2022, 225(4): 608-616. doi:10.1093/infdis/jiab486.
doi: 10.1093/infdis/jiab486 URL |
[36] |
Drever K, Lim ZL, Zriba S, et al. Protein Synthesis and Degradation Inhibitors Potently Block Mycobacterium tuberculosis type-7 Secretion System ESX-1 Activity. ACS Infect Dis, 2021, 7(2): 273-280. doi:10.1021/acsinfecdis.0c00741.
doi: 10.1021/acsinfecdis.0c00741 pmid: 33534536 |
[37] |
Wang Q, Boshoff HIM, Harrison JR, et al. PE/PPE proteins mediate nutrient transport across the outer membrane of Mycobacterium tuberculosis. Science, 2020, 367(6482): 1147-1151. doi:10.1126/science.aav5912.
doi: 10.1126/science.aav5912 URL |
[1] | Zhong Miner, Du Yuhua, Zhang Danni, Lin Ying, Wu Guifeng, Wang Ting, Liu Jianxiong. Analysis of latent tuberculosis infection among middle school and university freshmen in Guangzhou from 2018 to 2021 [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(2): 115-119. |
[2] | Luo Yi, Tao Fengxi, Li Guofei, Zhang Huihui, Peng Peng, Ren Yi, Liu Suyang. Environmental monitoring and analysis of Mycobacterium tuberculosis and discussion on the effect of disinfection equipment in a tuberculosis hospital [J]. Journal of Tuberculosis and Lung Disease, 2023, 4(2): 135-140. |
[3] | Luo Dan, Chen Songhua, Zhang Yu, Wang Wei, Wu Qian, Wu Yonghao, Liu Kui, Chen Bin. Analysis on the current status and trend of MTB/HIV co-infection screening in Zhejiang Province from 2015 to 2021 [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(6): 443-448. |
[4] | Cao Xuefang, He Yongpeng, Gao Lei. Research progress in current situation of Mycobacterium tuberculosis infection and preventive treatment in HIV/AIDS population [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(6): 511-516. |
[5] | Liu Yuanyuan, Li Lu, Wu Tuoya, Lu Jie. Research progress on the Mce4 protein family of Mycobacterium tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(5): 415-419. |
[6] | ZHOU Ming, LIU Huang-rong, TANG Liu-sheng, LIU Sang, LIU Ai-mei. Research progress on drug resistance of Mycobacterium tuberculosis to Delamanid and its molecular mechanism [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(2): 153-157. |
[7] | ZHANG Si-qi, LI Jing, WU Qian-hong. Application value of Mycobacterium tuberculosis scanning system in tuberculosis diagnosis [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(2): 170-172. |
[8] | QIU Yong, LI Meng, QU Rong, TIAN Fa-jun. Analysis of manual liquid culture method in county-level laboratory to detect Mycobacterium tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2022, 3(2): 173-176. |
[9] | YANG Kui, CHEN Wei. Advances about screening and preventive treatment of Mycobacterium tuberculosis latent infection in students [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(4): 361-365. |
[10] | SONG Yi-yan, CHEN Jie, LI Fang-hua, LI Ruo-nan, ZHAO Jing, YU Da-wei, SONG Hua-feng, XU Jun-chi, WU Min-juan, XU Ping. Analysis of 44 drug resistance patients with tuberculosis and received repeated treatment [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(3): 239-242. |
[11] | FENG Xin, HU Yan, SHEN Jing, ZHAN Jian. Analysis of Mycobacterium tuberculosis drug resistance in drug-resistance monitoring sites in Chongqing Municipality (2014-2019) [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(3): 251-255. |
[12] | LI Jing, ZHANG Yan, WU Qian-hong. Research progress on free DNA detection of Mycobacterium tuberculosis of non-sputum samples in tuberculosis diagnosis [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(3): 277-282. |
[13] | YAN Jin-yu, ZOU Tao, GUO Jian, XU Yong, TANG Pei-jun, FENG Yan-jun. Analysis of clinical features of Mycobacterium intracellulare pulmonary disease and Mycobacterium kansas pulmonary disease [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(3): 294-297. |
[14] | LIAO Xiao-qin, LIN Jian-dong, WU Di, CHEN Xiao-hong. Analysis of the clinical characteristics of Mycobacterium avian complex pulmonary disease and the risk factors of treatment effect [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(2): 120-124. |
[15] | ZHOU Bi-xia, YUAN Gong-ling, ZENG Ling-wu, ZHU Yi, CHENG Xi, LI Min, WU Mei-ying. Comparative analysis of CT signs of Mycobacterium kansasii pulmonary disease and pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2021, 2(2): 125-130. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||